This session will explore HIV pre-exposure prophylaxis (PrEP) as a highly effective yet underutilized prevention strategy for college students. Participants will review the clinical benefits of Yeztugo (lenacapavir), including findings from the PURPOSE 1 and PURPOSE 2 clinical trials, and will discuss its potential use in clinical practice. The session will highlight how new PrEP options may expand HIV prevention access and support student health on campus.
Speaker:
Kellie Hale, AGNP-BC, AAHIVS
Fair Haven Community Healthcare
This event is supported by Gilead
Disclaimer: American College Health Association does not endorse any company, product, or service presented in industry-sponsored webinars. Presentation content is not part of American College Health Association’s accredited education programming. Presentation content may include product promotion.
Details
02/18/2026
12:00 pm - 1:00 pm
Event Type
Industry Presentations
Topic
Infectious Diseases, LGBTQ+ Health & Wellness, Public Health, STIs
